14
Sep
On 29 August, the Therapeutic Goods Administration (TGA) provisionally approved Moderna's bivalent COVID-19 vaccine, SPIKEVAX Bivalent Original/Omicron, for use as a booster dose in adults 18 years and over. This is the...